DTL
Basic information
Region (hg38): 1:212035553-212107400
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DTL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 22 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 4 | 1 |
Variants in DTL
This is a list of pathogenic ClinVar variants found in the DTL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-212035901-A-G | not specified | Uncertain significance (Oct 20, 2023) | ||
1-212043027-G-A | Likely benign (Feb 01, 2023) | |||
1-212043044-G-C | not specified | Uncertain significance (Aug 16, 2022) | ||
1-212043115-T-A | not specified | Uncertain significance (Nov 18, 2022) | ||
1-212044752-T-G | not specified | Likely benign (Dec 19, 2023) | ||
1-212047174-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
1-212064996-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
1-212065019-C-T | not specified | Uncertain significance (Dec 19, 2023) | ||
1-212066855-A-T | not specified | Uncertain significance (Mar 02, 2023) | ||
1-212068629-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
1-212068674-T-A | not specified | Uncertain significance (Jan 09, 2024) | ||
1-212068700-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
1-212072205-A-G | not specified | Uncertain significance (Nov 11, 2024) | ||
1-212078197-A-G | not specified | Uncertain significance (Oct 08, 2024) | ||
1-212078228-C-T | not specified | Uncertain significance (Nov 12, 2021) | ||
1-212078239-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
1-212080704-G-A | Likely benign (Feb 01, 2023) | |||
1-212100303-G-A | not specified | Uncertain significance (Oct 06, 2024) | ||
1-212100383-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
1-212100397-T-G | not specified | Uncertain significance (Aug 15, 2023) | ||
1-212100411-C-G | not specified | Uncertain significance (Nov 12, 2021) | ||
1-212100487-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
1-212100542-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
1-212100549-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
1-212100555-C-T | not specified | Uncertain significance (Jun 18, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DTL | protein_coding | protein_coding | ENST00000366991 | 15 | 71824 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00330 | 0.997 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.78 | 291 | 390 | 0.747 | 0.0000196 | 4741 |
Missense in Polyphen | 55 | 96.97 | 0.56718 | 1189 | ||
Synonymous | -0.486 | 152 | 145 | 1.05 | 0.00000782 | 1426 |
Loss of Function | 4.03 | 12 | 39.2 | 0.306 | 0.00000204 | 460 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000120 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000133 | 0.000114 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000272 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control, DNA damage response and translesion DNA synthesis. The DCX(DTL) complex, also named CRL4(CDT2) complex, mediates the polyubiquitination and subsequent degradation of CDT1, CDKN1A/p21(CIP1), FBH1, KMT5A and SDE2 (PubMed:16861906, PubMed:16949367, PubMed:16964240, PubMed:17085480, PubMed:18703516, PubMed:18794347, PubMed:18794348, PubMed:19332548, PubMed:20129063, PubMed:23478441, PubMed:23478445, PubMed:23677613, PubMed:27906959). CDT1 degradation in response to DNA damage is necessary to ensure proper cell cycle regulation of DNA replication (PubMed:16861906, PubMed:16949367, PubMed:17085480). CDKN1A/p21(CIP1) degradation during S phase or following UV irradiation is essential to control replication licensing (PubMed:18794348, PubMed:19332548). KMT5A degradation is also important for a proper regulation of mechanisms such as TGF-beta signaling, cell cycle progression, DNA repair and cell migration (PubMed:23478445). Most substrates require their interaction with PCNA for their polyubiquitination: substrates interact with PCNA via their PIP-box, and those containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to their degradation. In undamaged proliferating cells, the DCX(DTL) complex also promotes the 'Lys-164' monoubiquitination of PCNA, thereby being involved in PCNA- dependent translesion DNA synthesis (PubMed:20129063, PubMed:23478441, PubMed:23478445, PubMed:23677613). {ECO:0000269|PubMed:16861906, ECO:0000269|PubMed:16949367, ECO:0000269|PubMed:16964240, ECO:0000269|PubMed:17085480, ECO:0000269|PubMed:18703516, ECO:0000269|PubMed:18794347, ECO:0000269|PubMed:18794348, ECO:0000269|PubMed:19332548, ECO:0000269|PubMed:20129063, ECO:0000269|PubMed:23478441, ECO:0000269|PubMed:23478445, ECO:0000269|PubMed:23677613, ECO:0000269|PubMed:27906959}.;
- Pathway
- DNA Repair;Post-translational protein modification;Metabolism of proteins;Neddylation;Recognition of DNA damage by PCNA-containing replication complex;DNA Damage Bypass
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.623
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.41
Haploinsufficiency Scores
- pHI
- 0.773
- hipred
- Y
- hipred_score
- 0.602
- ghis
- 0.612
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dtl
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- dtl
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- flat
Gene ontology
- Biological process
- protein polyubiquitination;DNA replication;ubiquitin-dependent protein catabolic process;protein monoubiquitination;cellular response to DNA damage stimulus;response to UV;positive regulation of G2/M transition of mitotic cell cycle;translesion synthesis;DNA damage response, detection of DNA damage;post-translational protein modification;positive regulation of protein catabolic process;regulation of cell cycle;signal transduction involved in G2 DNA damage checkpoint
- Cellular component
- nucleus;nucleoplasm;chromosome;nucleolus;centrosome;cytosol;Cul4A-RING E3 ubiquitin ligase complex;Cul4B-RING E3 ubiquitin ligase complex;nuclear membrane;Cul4-RING E3 ubiquitin ligase complex
- Molecular function
- ubiquitin-protein transferase activity;protein binding